|
News Release
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 08:49AM
|
|
Re: Merck and Pfizer competition for a COVID 19 pill (Stat News)
|
7
|
Resverlogix Corp.
|
Apr 15, 2021 09:03AM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 01:24PM
|
|
STAT News article on stopping COVID 19
|
7
|
Resverlogix Corp.
|
May 21, 2020 09:19AM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
7
|
Resverlogix Corp.
|
Sep 01, 2021 12:36PM
|
|
Merck and Pfizer competition for a COVID 19 pill (Stat News)
|
7
|
Resverlogix Corp.
|
Apr 09, 2021 12:34PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
7
|
Resverlogix Corp.
|
Oct 14, 2020 11:20AM
|
|
Re: Resverlogix Reschedules Update Webcast and Conference Call: Now February 4th 10AM MT
|
7
|
Resverlogix Corp.
|
Jan 27, 2021 06:45PM
|
|
Re: June 9th NR
|
6
|
Resverlogix Corp.
|
Jun 14, 2020 11:49AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 08:47AM
|
|
Upgrade ? PP ? COVID 19 ?
|
6
|
Resverlogix Corp.
|
Jan 18, 2021 02:42PM
|
|
Re: Interim Analysis
|
6
|
Resverlogix Corp.
|
Oct 16, 2020 09:29AM
|
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
6
|
Resverlogix Corp.
|
Oct 26, 2020 10:32AM
|
|
Re: Reading (parsing, fantasizing) the tea leaves - COVID & RVX 208
|
6
|
Resverlogix Corp.
|
Jan 31, 2021 11:05AM
|
|
Hepalink - Warrants expired
|
6
|
Resverlogix Corp.
|
Aug 20, 2020 10:19AM
|
|
Re: The therapeutic potential of BRD4 in cardiovascular disease
|
6
|
Resverlogix Corp.
|
May 20, 2020 08:50AM
|
|
Re: Up Up Up
|
6
|
Resverlogix Corp.
|
Sep 17, 2020 03:03PM
|
|
In regards to the share price and trading...
|
6
|
Resverlogix Corp.
|
Mar 19, 2021 10:21AM
|
|
Re: Resverlogix Secures One-Year Extension of Maturity Date of Debenture
|
6
|
Resverlogix Corp.
|
Jul 22, 2020 11:28AM
|
|
2 more directors exercise 50,000 options each
|
6
|
Resverlogix Corp.
|
Aug 04, 2020 08:02PM
|
